135 related articles for article (PubMed ID: 32502048)
1. The effect of age distribution on the prognosis of retroperitoneal neuroblastoma.
Liu X; Zhao J; Zhang L; Huang J; Ma Y
Medicine (Baltimore); 2020 Jun; 99(23):e20639. PubMed ID: 32502048
[TBL] [Abstract][Full Text] [Related]
2. Pediatric retroperitoneal non-organ-originated malignancies: An analysis based on SEER database.
Shen W; Geng H; Zhou Y; Yang X
Medicine (Baltimore); 2023 Oct; 102(40):e34910. PubMed ID: 37800819
[TBL] [Abstract][Full Text] [Related]
3. Survival of high-risk pediatric neuroblastoma patients in a developing country.
Easton JC; Gomez S; Asdahl PH; Conner JM; Fynn AB; Ruiz C; Ojha RP
Pediatr Transplant; 2016 Sep; 20(6):825-30. PubMed ID: 27235336
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With the Improved Survival of Head and Neck Neuroblastomas Compared to Other Body Sites.
Kaufmann MR; Camilon PR; Janz TA; Levi JR
Ann Otol Rhinol Laryngol; 2019 Mar; 128(3):241-248. PubMed ID: 30565471
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study.
Yan P; Qi F; Bian L; Xu Y; Zhou J; Hu J; Ren L; Li M; Tang W
Med Sci Monit; 2020 Nov; 26():e927218. PubMed ID: 33249420
[TBL] [Abstract][Full Text] [Related]
6. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.
Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET
Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
Nathan H; Raut CP; Thornton K; Herman JM; Ahuja N; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 Dec; 250(6):970-6. PubMed ID: 19644351
[TBL] [Abstract][Full Text] [Related]
8. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
Cotterill SJ; Pearson AD; Pritchard J; Foot AB; Roald B; Kohler JA; Imeson J
Eur J Cancer; 2000 May; 36(7):901-8. PubMed ID: 10785596
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma in childhood.
DeLorimier AA; Bragg KU; Linden G
Am J Dis Child; 1969 Sep; 118(3):441-50. PubMed ID: 5807651
[No Abstract] [Full Text] [Related]
10. Prognostic impact of tumor size on patients with neuroblastoma in a SEER-based study.
Wang JX; Cao ZY; Wang CX; Zhang HY; Fan FL; Zhang J; He XY; Liu NJ; Liu JB; Zou L
Cancer Med; 2022 Jul; 11(14):2779-2789. PubMed ID: 35315591
[TBL] [Abstract][Full Text] [Related]
11. Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients.
Gutierrez JC; Fischer AC; Sola JE; Perez EA; Koniaris LG
Pediatr Surg Int; 2007 Jul; 23(7):637-46. PubMed ID: 17476512
[TBL] [Abstract][Full Text] [Related]
12. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
[TBL] [Abstract][Full Text] [Related]
13. The observation of congenital retroperitoneal large size neuroblastoma.
Starchenko II; Dyachenko LV; Prylutskyi ОK; Vynnyk NI; Filenko BM
Exp Oncol; 2019 Jun; 41(2):179-181. PubMed ID: 31262150
[TBL] [Abstract][Full Text] [Related]
14. Decrease in childhood neuroblastoma death in Japan.
Hanawa Y; Sawada T; Tsunoda A
Med Pediatr Oncol; 1990; 18(6):472-5. PubMed ID: 2233518
[TBL] [Abstract][Full Text] [Related]
15. Stage IV-S neuroblastoma. Results with definitive therapy.
Stokes SH; Thomas PR; Perez CA; Vietti TJ
Cancer; 1984 May; 53(10):2083-6. PubMed ID: 6704896
[TBL] [Abstract][Full Text] [Related]
16. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.
Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z
Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of a patient with disseminated neuroblastoma.
Fiorillo A; Migliorati R; Tamburrini O; Pellegrini F; Vecchio P; Buffolano W; De Bernardi B
J Pediatr; 1982 Oct; 101(4):564-6. PubMed ID: 7119956
[No Abstract] [Full Text] [Related]
18. [Diagnosis and treatment of neuroblastoma in children--analysis of 98 patients].
Jin BX
Zhonghua Zhong Liu Za Zhi; 1986 Mar; 8(2):118-21. PubMed ID: 3769741
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Patients with Adrenal Neuroblastoma: A SEER Analysis, 2004-2013.
Chen S; Tang W; Yang R; Hu X; Li Z
Am Surg; 2020 Feb; 86(2):127-133. PubMed ID: 32167055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
